An increasing amount of evidence has shown that epitopes restricted to MHC class I molecules and recognized by CTL need not be encoded in a primary open reading frame (OR.F). Such epitopes have been demonstrated after stop codons, in alternative reading frames (RF) and within introns. We have used a series of frameshifts (FS) introduced into the Influenza A/PR/ 8/34 nucleoprotein (NP) gene to confirm the previous in vitro observations of cryptic epitope expression, and show that they are sufficiently expressed to prime immune responses in vivo. This presentation is not due to sub-dominant epitopes, transcription from cryptic promoters beyond the point of the FS, or internal initiation of translation. By introducing additional mutations to the construct exhibiting the most potent presentation, we have identified initiation codon readthrough (termed scanthrough here, where the scanning ribosome bypasses the conventional initiation codon, initiating translation further downstream) as the likely mechanism of epitope production. Further nmtational analysis demonstrated that, while it should operate during the expression of wild-type (WT) protein, scanthrough does not provide a major source of processing substrate in our system. These findings suggest (i) that the full array of self-and pathogen-derived epitopes available during thymic selection and infection has not been fully appreciated and (it) that cryptic epitope expression should be considered when the specificity of a CTL response cannot be identified or in therapeutic situations when conventional CTL targets are limited, as may be the case with latent viral infections and transformed cells. Finally, initiation codon readthrough provides a plausible explanation for the presentation of exocytic proteins by MHC class I molecules.
C
D8+cytotoxic lymphocytes (CTL) recognize and respond to the products of protein degradation (epitopes) associated with MHC class I molecules at the cell surface (1) (2) (3) (4) (5) . It has been generally assumed that degradation of full-length protein supplies the majority of epitope for antigen presentation. However, there are many instances reported in the literature describing presentation from gene fragments and mini-genes that encode only the epitope (6) (7) (8) , implying that full-length protein is not a requirement for efficient antigen presentation to CTL. More surprisingly, evidence exists that questions the basic assumption that epitopes must to be encoded in primary open reading frames. Examples include the presentation of epitopes that follow stop codons (9) , are encoded in alternate translation reading frames (10) (11) (12) (13) , are presented in the absence of any obvious initiation codons (14) or are even processed and presented in the apparent absence of a related promoter (15) . Explanations that have been proposed to account for these unusual circumstances include ribosomal frameshifting (11, 13) , alternative translation initiation codons (14) and the possibility of subgenic transcription events (the pepton hypothesis; 16). However, in most cases the underlying mechanism(s) have not been elucidated.
Until recently, cryptic epitope expression had remained an in vitro phenomenon. The immunological significance of unconventionally produced epitopes has now been demonstrated. An immunogenic human melanoma epitope has been mapped to a region of a novel gene encoded partially by exon 2 and the following intron (17) , implying that the epitope is expressed only when imprecise splicing events occur. The mutation that elicits the CTL response is encoded in the intron, outside of the primary open reading frame (ORF) ~. Wang et al. have mapped responses of a melanoma-specific CTL line to a peptide encoded within an alternate reading frame of the gp75 gene (12) . An earlier study by Uenaka et al. (18) , in which a murine leukemiaspecific epitope was mapped to the 5' untranslated region of the gene, suggests that alternative translation mechanism may also provide cryptic epitopes in vivo. In a more con1Abbreviations used in this paper: BFA, brefeldin A; FS, frameshift; NP, nucleoprotein; OR.F, open reading frame; P,F, reading frame; UTR, untranslated region; vac, vaccinia virus; WT, wild-type. trolled system, Elliott et al. have demonstrated the ability to prime mice to an epitope shifted to an alternate reading frame by a single base deletion (13) .
The potential for unconventional epitopes to be encoded in alternative reading frames (RF) and untranslated regions (UTR) requires that the whole mP-.NA, not just the primary RF, be considered for examination when determining possible substrates for efficient antigen processing and presentation. In addition to providing a new array of epitopes, these mechanisms could provide a source of conventional R.F substrate that is, by virtue of its abbreviated form, more efficiently processed and presented than fulllength proteins. For both in-frame and out-of-frame epitopes this may be more c o m m o n than generally imagined. Additionally, epitopes in alternate reading frames may be important contributors to immune responses in vivo, involved in the activation of autoimmune disorders and of benefit in targeting CTL responses in cancer immunotherapy.
Several potential explanations for the production of cryptic epitopes are available for consideration, including many at the level o f translation. The inherent flexibility o f the scanning and translating ribosome has produced variants of conventional translation (19) that could provide a basis for cryptic epitope expression, including: (0 initiation codon scanthrough (where the scanning ribosome bypasses the 5' A U G and initiates at an A U G further downstream; references [20] [21] [22] ; (i 0 reinitiation of translation (where a ribosome that has terminated translation does not dissociate from the message and begins translation at a downstream A U G codon (22) (23) (24) ; (iiO ribosomal frameshifting (the scanning ribosome changes RFs in mid-translation, a process greatly enhanced by the presence of a "slippery site", upon which the ribosome shifts and a "pseudo-knot", which causes the ribosome to pause over the slippery site (25, 26) ; (iv) translation termination readthrough (the context of the stop codon is insufficient to cause 100% of translating ribosomes to terminate; references 27, 28); and (v) internal initiation of translation (an internal ribosome entry site provides a "landing pad" for ribosomes to initiate translation from internal AUGs; references [29] [30] [31] .
To elucidate the mechanism and gauge the potential of cryptic epitope production, we have imposed a series of controlled genetic changes upon the influenza A PR./8/34 nucleoprotein (NP) gene, predicted to prevent the translation o f some or all o f three well-defined and broadly spaced M H C class I-restricted epitopes. These manipulations not only confirmed the possibility of cryptic epitope expression, but further demonstrated in vitro and in vivo that cryptic translation is a physiologically relevant and an immunologically important mechanism for supplying substrate to the M H C class I antigen processing and presentation pathway.
Materials and Methods
Chemicals. General chemical supplies were obtained from Sigma Chem. Co. (St. Louis, MO). Molecular biology reagents were obtained from New England Biolabs (Beverly, MA), except where noted.
Animals. 6-8-wk-old female inbred CBA (H2-k), BALB/c (H2-d) and C57B1/6 (H2-b) strain mice were obtained from Taconic (Albany, NY) or Jackson Labs (Bar Harbor, ME) and maintained in Thomas Jefferson University Animal Facilities. Tissue Culture. L929 (H-2Kk), L-Kd (H2-K k, H2-K~; L929 transfected with H2-Kd; reference 32), and MC57G (H2-D t') cells were grown in DMEM supplemented with 5% FCS (Sigma), 37~ CO> Molecular Mallipulations. All enzymes used for the manipulation of the NP gene were used according to manufacturers directions. PCP-. primers and oligonucleotide linkers were synthesized by Kimmel Cancer Institute Nucleic Acid Facility. NP containing a silent ApaI site in the H2-K a (bp457-463) epitope has been described elsewhere (8) . PCR. directed mutagenesis was used to incorporate a silent AatlI site in the H2-K k epitope (bp165-171): GAG GGA CGT CTG ATC. These altered sites were then used in additional cloning of the NP gene. Most manipulations were done using a Bluescript II SK + / -vector (Stratagene Inc., La Jolla) with NP inserted in the EcoR.l site into the multiple cloning site.
A similar strategy was used to insert an NheI site into NP3f,~,_374.
Frameshifts. Frameshift A (FS-A) was created by encoding a dropped base 5(C) and a Sail site in a 5' primer annealing to the 5' end of NP (TCG CAG TCG ACA TCA AAA TCA TGG GTC CCA A). A 3' reverse primer encompassing the AatlI site at bp165-171 allowed the production of a fragment for ligation, after digesting with Sail and Aatll, into NP-Bluescript cut with Sail and AatlI. This was then shuttled into pSC11 (8) via the SalI and Notl restriction sites for vaccinia (vac) recombination. FSs B through E were created by cutting NP with AatIl, Narl, ApaI, or AvrlI restriction enzymes, respectively. The resulting digests were then incubated with DNA polymerase Large Fragment (Klenow fragment) and then religated (T4 DNA ligase; GIBCO BRL, Gaithersburg, MD). Ligation reactions were used to transtbrm competent DH5ot E. coil Transformants were screened for loss of the restriction site and then sequenced to confirm the nmtation. Mutant NP fragments were then cloned into pSC11.
Substitutious. Due to the location of the ATG codons that we wished to ablate, two-step primer directed PCR nmtagenesis was used. A PCP,. primer pair encoding an ATG to ATC substitution and the appropriate surrounding sequence were used in independent reactions with the 5' primer pairing with an NP-specific 3' primer, and the 3' primer pairing with an NP-specific 5' primer. FS-A DNA was used as the template. The products of the independent PCR.s were gel purified to remove any surplus primers. The PCP, products were then mixed and allowed to anneal and extend in the absence of primers for three rounds ofa PCIZ. The flanking distal primers used in the first reaction were then added for the remaining cycles. The resultant extended PCI% encoding the mutations, was ethanol precipitated and subject to restriction digestion for ligation into FS-A.
Epitope Knockouts. PCR primers encoding substitutions of the anchor residues were used to direct elimination of the H2-K k, H2-K d, and H2-D b epitopes. TTG GAT CAG ACG TCC CTC ATA AGT ACT encodes a D51T substitution and a silent Scal reporter site. AAC AAG GCC CCT CGT ACG CTG TGC AGT TGC encodes a Yt48A and a silent BsiW1 reporter site. These two oligos were used for 3' priming PCIZs with 5' primers spanning the SalI site at the front of the gene. GTT CAA ATT GCT AGC AAT GAA GCT ATG encodes a 5' primer with a N370A substitution and a silent Nhel site. This was used for a PCP,. reaction, paired with a vector derived 3' primer, to create a fragment from the NheI site to the NotI site at the end of the gene.
NP/M32IMutant. Complementary oligonucleotides direct-
ing an ATG to ATC mutation (GTC GGA AAA ATC ATT GGT and ACC AAT GAT TTT TCC GAC) were used in a two-step PCR reaction, in combination with primers annealing to the region encompasing the Sail site preceding the gene and the engineered ApaI site within the NP/147-155 epitope. The PCR product was trimmed with Sail and ApaI and then used to replace the wild-type sequence between Sail and ApaI.
Thermostable Duplex Barrier. The first stage of the barrier was created using a 5' PCR primer encoding the left hand side of the barrier, the KpnI loop and an XbaI cloning site. This was used in conjunction with a SalI containing 3' primer, that anneals to the front of the NP gene, to produce a fragment that inserted between the XbaI and SalI sites in NP-Bluescript. The second stage 5' primer encoded the KpnI loop at the 5' end, the right hand side of the barrier and a 3' SalI site. In conjunction with a 3' primer that anneals to internal NP sequence, a PCR fragment was produced that formed the duplex when inserted at the KpnI site of the first fragment (using an internal NP AatlI site as the other restriction point). The completed duplex barrier-NP fragment was cloned into pSC11 by digestion at the XhoI and NotI restriction sites, taking advantage of the cohesive end compatibility between Sall and Xhol. Primer sequences were (0 first stage: ACG CTC GAG GGG GCG CGT GGT GGC GGGGTA CCA CGC GTC GAC GGT ATC GCG ATA AG and (i 0 second stage: CGG GGT ACCCCG CCA CCA CGC GCC CCG CTC GAC CAC CAT GGT GTC. Viruses. Vaccinia recombinants were made as previously described (8) . Briefly all altered genes were ligated between the Sail and NotI sites in modified pSC11 for expression from the P7.s promoter. These plasmids were then introduced into the vaccinia genome via homologous recombination in CV-1 cells (CCL 70; ATTC) and plaque purified in 143B HuTK-(CRL 8303; ATTC) cells in the presence ofBrdU (Boehringer Mannheim, Indianapolis, IN). In all cases the integrity of the recombinant was determined by isolating vac DNA and sequencing after PCR amplification of the mutant gene. Additionally, viral expression products were analyzed by northern blotting to confirm mRNA size. Control vac used in the experiments were generated by recombining the pSC11 plasmid with no insert into the vac genome.
CTL Assay. APC were infected for 1 h at 37~ with vaccinia recombinants at 10 PFU/cell at a concentration of 107 cells/ml in balanced salt solution containing 0.1% BSA. After 1 h, 10 ml of preconditioned (37~ 9% CO2) DMEM + 5% FCS was added and the cells incubated a further 3 h with rotation. Cells were pelleted and resuspended with 50 /,1/ 106 cells of IMDM with 7.5% FCS containing 100 /*Ci of NaSlCrO4 (Amersham Corp.) and incubated for 1 h at 37~ APC were then washed three times with DPBS and resuspended in IMDM and combined with CTL populations in round-bottom plates at 104 cells/well. APCs and CTL were coincubated for 4 h at 37~ before 100/~1 ofsupernatants were collected and counted in a gamma detector (Wallac, Turku, Finland). The data are presented as percent specific SlCr, defined as 100 • ([experimental cpm -spontaneous cpm]/[total cpm -spontaneous cpm]). In some assays Brefeldin A (BFA) was added to a final concentration of 5 Ixg/ml and maintained at that concentration until harvest of supernatants.
Generation of CTL. CTL restricted to H2-K k, H2-K a, or H2-D b
were derived from NP immunized CBA, BALB/c or C57BL/6 mice, respectively, as described elsewhere (33) . Mice were immunized by intraperitoneal injection of 10 v PFU of NP-vac. After at least 2 wk, spleens from appropriate mice were harvested and one-third of cells infected with PR8 for restimulation. Secondary cultures were incubated at 37~ CO2 for 6-7 d before harvesting for effector populations. For in vivo priming assays, duplicate mice were injected intraperitoneal with 4 • 106 PFU of each recombinant vac and left for 2 wk before splenocytes were restimulated in vitro with PR8 or wild-type vaccinia vires.
Results

Construction of Out-of-Frame Epitopes in Influenza Nudeoprotein.
To pursue studies on the contribution of epitopes encoded in alternate reading frames to MHC class I-mediated immune responses, we introduced a series of FSs (depicted in Fig. 1 ) into the NP gene. NP contains three welldefined MHC class I epitopes, which encompass amino acids 50-57 (NP50_s7: H2-K k restricted), 147-155 (NP147_IS5: H2-K d restricted), and 366-374 (NP366_374: H2-D b restricted) (34) (35) (36) (37) . The FS series is predicted to have diverse effects on the production of the three epitopes. For example, frameshift A (FS-A) is a shift into the + 1 RF (where the primary ORF is defined as RF0) at the second codon. This is predicted to cause termination at codon 16, which would lead to no epitope production by conventional translation. Even if all termination codons in the + 1 RF were to be ignored by the translating ribosome, translation of the regions encoding the three epitopes will produce nothing resembling NPso_s7, NP147_lSS, or NP366_374, as shown in Fig. 1 . The frameshifted mutant NP genes were recombined into the vaccinia virus (vac) genome and the resultant viruses were checked for fidelity by PCR amplification and sequencing of the altered gene. Immunofluoresence staining of cells infected with the vac recombinants, using an antibody that precipitates NPlqs8 (HB-65), yielded no specific signal and initial NP-immunoprecipitations from cells infected with the vac recombinants, using monoclonal antibodies having complementary specificities, did not yield any specific bands (data not shown). having been shifted out of the conventional RF (10, 11, 13, 14) . To determine whether this was true for our constructs using the vac expression system, each was tested for presentation of all three NP epitopes. Cells expressing the H2-K k, H2-K a, or H2-D b MHC class I molecules were infected with the vaccinia recombinants and incubated with secondary culture CTL derived from CBA (H-2k), BALB/c (H-2d), and C57B1/6 (H-2 b) mice immunized to NP. Because the location of the FSs and the consequential effect on NP translation, presentation would be predicted to differ for each construct. FS-A: (a shift into the +l 1KF at codon 2, predicted to terminate at codon 33) is not predicted to present any of the epitopes, although a previous study with a similar mutant (10) showed retained presentation of NPs0_57 and NP147_155. Our results confirm and extend those findings, in that all three epitopes are presented in the face of FS-A. Frameshift B (FS-B: a shift to the -1 frame at codon 55 (actually within the NPs0_s7 epitope), predicted to terminate at codon 70) is also predicted to prevent presentation of all three epitopes. When assayed, presentation of NPs,_.w and NP147_lS 5 are indeed ablated, while NP366_374 is surprisingly still capable of sensitizing target cells to CTL-mediated lysis. Frameshift C (I=S-C: a shift to the +1 frame at codon 121, terminating at codon 151) maintains presentation of NPs0_57 (as expected since the FS occurs after this epitope) but is unable to present NPHT_155. In contrast, NP3(,6_.w 4 is presented when expressed from this nmtant, though at much reduced levels in comparison to FS-A and FS-B. Frameshift D (FS-D: a shift to the +1 frame at codon 151, terminating at codon 164) presents partially as predicted, with NP50_s7 retaining presentation, NPHT_155 not presented (as the FS is within this epitope) and NP3~,~,_374 presented slightly above control vac. This very low level of presentation was consistently observed in many independent assays. Frameshift E (FS-E: directs a shift to the -1 frame at codon 175, temainating at codon 201) is Figure 2 . In vitro presentation of NP frameshift recombinants. APC expressing H2-K k (L-Kd), H2-K d (g-Kd), or H2-D u (MC57G) were infected for 4 h with vaccinia recombinants before SlCr labeling and incubation with NP-specific CTL generated by priming with NP vac and restimulating in vitro with PP,.8 as described in Materials and Methods. NP-Vac and FS-A are presented to all haplotypes, WT control vac is presented on none and FS-B, FS-C, FS-D, and FS-E are presented at different degrees to each haplotype. Vac restimulated splenocytes were used to confirm equal infection of target APCs (data not shown).
Presentation of Out-of-frame Epitopes In
the only construct that performs completely as predicted, maintaining presentation of NP~_s7 and NPI47_15 ~ while losing any presentation of NP3(,(,_374 (Fig. 2) . It is especially noteworthy that presentation of the H2-D b epitope (NP3(,¢,_374) is proportional to the distance of the FS event from the 5' end of the gene. This conforms to Kozak's predictions for ribosomal reinitiation potential, in that the further the termination event is from the 5' cap, the less likely reinitiation is to occur (38) .
h~ Vivo Presentation of CrTptic Epitopes. Aside from a recent publication (13) , demonstration of alternative RF cryptic epitope presentation has been restricted to in vitro observations. Having established in our system that mechanisms exist that can overcome the effect of the FSs and enable translation at levels that are sufficient to sensitize the infected presenting cells in vitro, we wished to assess the ability of these epitopes to be presented in vivo. C57B1/6 (H-2 b) mice were inoculated with recombinant vac expressing FS-A, FS-B, FS-C, FS-E, NP-vac, or control vac. After 2 wk, their spleens were used to 1hake in vitro secondary cultures by restinmlation with P1K8. To confirm equal priming, a fraction of the splenocytes was restinmlated with wild-type (WT) vac (Fig. 3, sub-graphs) . Each of the CTL populations was tested in standard chromium release assays for specific lysis of cells infected with WT NP, presenting the NP366_374 epitope. The data in Fig. 3 show that, in addition to CTL from NP-primed mice, CTL derived from mice primed with FS-A and FS-B were capable of specifically lysing cells expressing WT NP. In contrast, FS-C and -E did not produce any significant priming. Therefore it is likely that the same mechanisms that are responsible for the production of cryptic epitopes in this scenario are available to the mmmne system during natural imnmne responses. It should be noted, however, that cryptic epitope expression in our system appears to be stronger when analyzed in vitro, compared to in vivo. Only FS-A and FS-B constructs were capable of printing responses to NP in vivo (with FS-B priming much poorer), while FS-A to FS-D were all detected in vitro. In Vitro Cryptic Epitope Presentation Is Not Due to Subdominant Epitopes. T o address the argument that antigen presentation observed from the expression o f these constructs is due to subdominant epitopes, w e created a series o f c o nstructs that should eliminate presentation o f the described epitopes. This is o f particular concern for the NP366_374 epitope as an observation by O u k k a et al. (39) showed that an additional H 2 -D b epitope exists at NP55_63. In their system this epitope was s h o w n to be p r o d u c e d at levels that are toleragenic, although this m i g h t not be true in a r e c o mbinant vac expression system. T h r e e separate N P mutants were constructed in which one o f the dominant M H C class I binding anchor residues was substituted with a n o n -a n c h o r a m i n o acid for each o f three epitopes: the substitutions were D51--+T51 (D51T, H2-Kk), Y148--+A148 (Y148A, H 2 -K d) and D370--+A370 (D370A, H2-Db), respectively, changes that are predicted to abrogate the binding o f the epitope to the restriction element. (40) . Fig. 4 shows that eliminating the respective anchor residue ofNPl47_155 and NP366_374 ablates presentation, while presentation o f NPs0_57 is severely curtailed. In each case, expression and presentation o f the unmutated epitopes were not affected. T h e in vivo response by H -2 b mice to F S -A could also be ascribed to recognition o f NP366_374; spleen cells from C57B1/6 mice primed with F S -A and restimulated with P R 8 did not respond to the D 3 7 0 A mutant (data not shown). These data imply that the presentation that is observed with the frameshifted c o nstructs is due to the translation o f the d o m i n a n t epitopes CBA (11-2 k) e, hip Vac !~1 ~IF' D51T "01 50 
In Vitro Presentation of Out-of-Frame Epitopes Is Not Due to Cryptic Promoter Activity or Internal Initiation of Translation.
Several alternative explanations, aside from cryptic translation, could account for the presentation o f the out-of-frame epitopes from cells infected with the vac recombinants. . lmmunoprecipitafion of frameshif~ed mutants of NP expressed from vaccinia recombinants. Cells were infected with the indicated vac recombinants for 6 h at 37~ in the presence of the proteasome inhibitor LLnL and were pulse labeled for 45 min with 3sS Met/Cys. Cells were lysed, pre-cleared and immunoprecipitations were carried out using NP-specific antibodies in the presence of protease inhibitors. Lane 1, control vac; lane 2, NP-vac; lanes 3-7, FS-A to -E; lane 8, NPI47 *vs. Arrow denotes the NP-specific FS-A product.
served could have been due to cryptic vac promoters within the N P gene. These could be located downstream o f the FS mutations and allow conventional translation of the primary O R F from R F 0. This is a potential explanation for the behavior of FS-B and FS-C (lack of presentation of NP147_ts s but presentation of NP366_374). To address this possibility, we inserted a thermostable duplex barrier between the P7.5 vac promoter and codon 1 of NP (Fig. 5 a) . Such a barrier is predicted to block the progression of a ribosome scanning from the 5' end of the N P gene, as previously demonstrated by Kozak using a similar structure (20) . Indeed we were not able to immunoprecipitate any specific product expressed from this construct (data not shown). If presentation is dependent upon the ribosome scanning unimpeded from the 5'-cap to AUG1, then expression o f the three epitopes in N P would be ablated. However, if cryptic vac promoters exist within the N P gene, the barrier would not be incorporated into the m R N A and translation of the epitopes should be unhindered. The data shown in Fig. 5 b demonstrate that there is a drastic reduction of presentation of all three epitopes. The remaining presentation seen for NPso_s7 and NP366_374 could be due t o some cryptic vac promoter activity at a level that can be detected by CTL. However, the graded presentation of NP366_374 with respect to the FS series argues against this possibility. The retained presentation may in fact be due to a biochemically undetectable amount o f leakiness in the duplex barrier. Certainly, the level of epitope expressed from this construct cannot account for the majority of NPso_s7 and NP3r 374 presentation seen with FS-A and FS-B. As more fully discussed below, we believe that NP147_l~ 5 is not an efficiently presented epitope. This is a feasible explanation for these results and others (Figs. 2 and 7 ) in which presentation of NPs0_sv and NP366_374 persists while that of NP147_ 155 is lost. This result also makes it very unlikely that internal initiation of translation is responsible for significant levels of cryptic epitope production, as this mechanism would also allow bypass of the thermostable duplex and translation from an internal entry site.
Immunoprecipitation of Frameshifted Constructs. Results de-
scribed thus far suggested that bypass of the frameshift mutations occurs in our system at the level of translation. Initial screens using a cocktail of NP-specific mAbs only immunoprecipitated N P from NP-vac-infected cells (data not shown). However, the products from cryptic translation are likely to be produced at low levels and may be inherently unstable. Therefore we repeated the screens in the presence of the proteasome inhibitor LLnL and the infected, pulsed ceils were lysed in the presence o f a protease inhibitor cocktail consisting of AEBSF (serine proteases), E D T A (metalloproteases), leupeptin (broad range), and pepstatin (acid proteases). As can be seen from 
Ribosomal Scanthrough to the AUG32 Codon Appears to Be the Mechanism Responsible for Presentation of FS-A.
The immunoprecipitable smaller band from FS-A suggested initiation at an internal A U G , either via reinitiation (after encountering a termination codon, in our case codon 33, the ribosome then proceeds to translate from a downstream AUG) or scanthrough (the ribosome bypasses AUGI in preference of an alternate downstream A U G , e.g., codon 13, 32, or 43). The shorter band also argues against an early natural frameshifting event by the ribosome as the product of this mechanism should be full-length. To discern between these possibilities, we eliminated two A U G start codons from FS-A in separate constructs (Fig. 7 a) . This was accomplished by primer directed mutagenesis, substituting A T G to A T C at either codon 13 or codon 32 within FS-A, affecting a methionine to isoleucine substitution (termed FS-A/M13I, or FS-A/M32I, respectively). When assayed in standard chromium release assays, presentation of FS-A was little affected by the M13I mutation (Fig. 7 b) . H o wever, the FS-A/M32I recombinant had virtually no ability to sensitize cells for CTL lysis. The severity of this single mutation on presentation was quite surprising given the persistence of presentation in the face of the FS mutations which might be considered to be much more severe manipulations of the gene. As with our other recombinants in this work, we have sequenced the relevant region of the vac genome and can find no changes other than those intended. This implies that AUG32 is intrinsically important in the translation of epitope for antigen presentation of FS-A. As there is no translation termination codon in the -1 reading frame (adopted by the ribosome after the FS) until codon 33, this also suggests that ribosomal scanthrough, and not reinitiation, is responsible for the production of out-of-frame epitopes from FS-A.
Initiation at AUG32 Does Not Provide a Major Source of Substrate in the Processing of Wild-type NP.
An attractive hypothesis proposed in several different forms is that products of aberrant gene expression are processed with particular efficiency due to their immediate targeting for degradation. With this concept in mind we tested the possibility that initiation at M32 is an important event even in the processing of wild-type NP. We employed site-directed mutagenesis to alter the thirty second codon of wild-type NP from A T G to ATC, effecting a M--+I change. The mutant appeared to be identical to W T NP in terms of stability and nuclear localization (data not shown). N P / M 3 2 I was also indistinguishable from wild-type NP in the presentation of NP147_155, the epitope that should be most sensitive to any compromise in the level of processing substrate (Fig. 8) . In this assay, target cells were pulsed with control virus, NP vac, and N P / M 3 2 I vac and then exposed to brefeldin A (BFA) at various points post infection for the remainder of the assay. BFA blocks transport of proteins to the cell surface and can therefore be used as an indirect measure of the relative efficiency with which class I-peptide complexes are formed (41) . Under these conditions, in which time points associated with sub-maximal presentation were clearly employed, the kinetics with which the epitope was formed from the wild-type and mutant proteins are essentially identical. Thus, scan-through to AUG32 does not appear to provide a significant source of processing substrate during the expression of wild-type NP. This result was supported by performing of a similarly structured assay in which the kinetics of NP366_374 expression from wild-type and FS-A were compared (not shown). The amount ofNP366_374 produced by infection with FS-A was significantly lower than that produced as a result of infection with W T NP vac.
Discussion
In this manuscript we provide evidence confirming and extending previous observations by others concerning the processing and presentation of cryptic epitopes (9) (10) (11) (12) (13) (14) 42) . Our in vitro presentation data concurs with the results of Fetten et al. and provides the additional support of a third nucleoprotein epitope, NP366_374. In comparison to all but one preceding study (13), we have used the recombinant vac expression system. For purposes of this study, this strategy offers several advantages over other expression systems. First, vac has a cytoplasmic replication cycle and therefore uncontrolled genomic integration and NP m R N A splicing are not an issue. Second, vac infects a wide range of cells which allows us to study the presentation of multiple, differentially restricted epitopes. Vac is also efficient at priming immune responses, permitting us to assess the antigenicity of cryptic epitopes in vivo (43, 44) .
The study of cryptic epitope expression has provided a forum for the debate as to whether CTL are sensitive to very low levels of antigen production. It has been proposed that antigen needs to be well expressed (detectable by conventional biochemistry) to elicit a CTL response (10), while others have suggested that CTL respond to vanishingly small amounts of epitope (14). Our results are more in agreement with the latter position. Immunoprecipitable quantities of FS-A were only achieved in the presence of proteasomal and protease inhibitors and we were not able to immunoprecipitate any product from FS-B infected cells (Fig. 6 ). Despite this, both FS-A and FS-B were well presented at NP366_374. The low levels of antigen produced from these mutant constructs (FS-A and FS-B) were also sufficient to prime NP-specific immune responses in vivo (Fig. 3) , confirming our in vitro results, and providing evidence that cryptic epitopes encoded in alternative R.Fs can play a significant role in natural immune responses. An important observation from these data is that not all of the FSs that could elicit CTL responses in vitro were capable of priming in vivo. This suggests that there is a difference in sensitivity levels between the two assay techniques arid care should be taken when assessing the true activity of cryptic epitopes in immune responses.
Two strategies that we adopted were very helpful in eliminating potential mechanisms underlying the initial results. First, point mutations at anchor residues in each of the conventional epitopes allowed us to ascribe virtually all of the bypass of the FS mutations to expression of NP50_57, NP147_Iss, and NP36(,_374 and not emergent subdominant epitopes. Second, the insertion of a thermostable duplex within the 5' U T R of the NP gene indicated that the majority of epitope production from the NP gene is due to translation proceeding from the 5' end of the NP gene, as opposed to either translation from abbreviated transcripts resultant from vac promoters within the NP gene, or from sites of internal initiation (Fig. 4) . The graded diminution in NP36{,_374 presentation as the FS became more distal (Fig. 2) also argues against the influence of cryptic vac promoter with NP. Ifa cryptic promoter within the NP gene was responsible for this low level of NP36()_374 expression, one would expect an abrupt loss of presentation with the first FS downstream of the promoter. The low level of H-2 b reactivity associated with the duplex construct seems likely to be due to biochemically undetectable leaking of scanning ribosomes through the thermostable duplex. This level of leakiness is probably not sufficient to elicit NP147_155 responses, however, as we believe NP14?_ls s is inefficiently processed relative to NPs0_sv and NP366_374. This is perhaps due to a major proteasomal cleavage site within the epitope itself (Yellen-Shaw, A., and L.C. Eisenlohr, manuscript in preparation), which would explain why its expression is absent with the duplex barrier in place. None of our manipulations completely ablated H-2 k reactivity and we believe it quite possible that there is a minor H-2 k -restricted epitope elsewhere in the NP gene. However, we do not think that this persistent low level of reactivity compromises our conclusions. In those cases where we observed H-2k-restricted epitope expression relevant to the central theme of this work (FS-A and FS-A/M13I), presentation levels were maximal and therefore almost entirely attributable to expression of NPs0_5v. These findings, therefore, permitted us to focus our attention on mechanisms at the level of translation.
Examination of our results with respect to the positioning of the FSs suggest that at least two variants of conventional translation account for cryptic epitope presentation. It is apparent from the introduction of ATG--+ATC substitutions superimposed upon FS-A, that AUG32 is nearly requisite for CTL responses to the products of FS-A. This nmtation determined that scanthrough was the probable mechanism at work for FS-A, as there are no termination codons between the FS event and codon 32. By definition, ribosomal reinitiation is not responsible for epitope expression from FS-A. The effect of the single point mutation on AUG32 initiated translation was startling in its severity considering that the substitution at AUG13 had no effect on the presentation of any of the epitopes under study (Fig. 7 b) . Scanthrough is not a vac-specific mechanism. It has been directly observed in transfected yeast and mammalian cells (22) (23) (24) and therefore should be possible under many conditions of gene expression.
Although we have shown that ribosomal scanthrough can successfully produce cryptic epitopes when initiating near the 5'-cap, a second mechanism seems likely to operate for FS-B expression as the distance from the 5'-cap that scanthrough can successfully operate appears limited. This is seen in the failure of AUG6{, to compensate for the loss of AUG32 in producing substrate for epitope excision, despite the excellent context surrounding this codon (CCG-GAAUGG; Kozak has defined good initiation context as CC(A/G)-3CCA+IUGG +4, with the purine at -3 being in place 97% of the time and the guanine at + 4 important in the absence of the -3 purine; reference 45). With this in mind, it is most likely that FS-B-expressed epitopes are produced by an alternate method. Reinitiation of translation seems a strong possibility. There are limitations to this mechanism with respect to both the length of the upstream O R F (23) and the intercistronic distance (24, 46, 47) , but many possible FS-B reinitiation events are still permitted by these criteria. The fact that NP366_374 is presented from FS-B
while NP]47qss is not suggests that reinitiation may occur downstream of NP147_ls s. However, there are several other influencing factors with NP147_/ss, principally its inefficient expression even from W T NP as mentioned above. A remaining question is why the FS-B expression mechanism is not available to FS-A/M32I. Theoretically, the AUG codon that is used for reinitiation in the expression of the three epitopes from FS-B should still be available for FS-A/M321 translation, unless the positioning of the two conventional translation termination codons (33 and 70, respectively) is significant. Experiments designed to elucidate the mechanism underlying the bypass of FS-B are ongoing and may shed light on this question.
Another demonstrated means of cryptic epitope expression is the initiation of translation at non-AUG codons (48) . These alternative codons include AUU, UGG, GAU, ACG, CUG, and GCG, of which the latter three are the more potent at initiation. Recent studies have shown that such codons are capable of driving the translation of an epitope in me absence of a conventional initiation codon (14). There is one in-frame alternative initiation codon (GAUl6) preceding AUG3,_ in NP and 2 (AUU33, AUU36 ) immediately following, all of which are in optimal initiation context. However, it is apparent from the effect of the AUG32 substitution that alternative translation initiation codons do not contribute significantly to epitope production from FS-A in our system, although this might have been different if the stronger alternative initiation codons had been available.
As a natural extension of our in vivo results, demonstrating the strong priming potential of FS-A, it seems likely that ribosomal scanthrough of the primary initiation codon (AUGD could be occurring during the production of proteins in vivo. Therefore, it is quite possible that this translation mechanism is providing processing substrate from alternative RFs for many genes in the natural situation. This is dependent upon the portion of the gene that scanthrough can use as a template, and whether this region of the gene encodes an immunogenic epitope. Although our data suggest that scanthrough is limited to the 5' end of mRNA, the potency of this mechanism is demonstrated by the ribosome bypassing four AUG codons and one alternative initiation codon before initiating translation at AUG32 (Fig. 7 a) . The scanthrough initiation is at a strength and frequency that enabled us to immunoprecipitate a polypeptide smaller than NP from recombinant vac infected cells, using NP-specific antibodies under the appropriate conditions. Furthermore, in a more controlled setting, we have confirmed the ability of ribosomes to ignore the 5' initiation codon (even those with excellent context) and utilize a downstream initiation codon in an alternative IKF to produce sufficient epitope for CTL activation (T.N.J. Bullock and L.C. Eisenlohr, manuscript submitted). Encouraged by this result, we have tested the possibility of identifying naturally expressed epitopes eneoded in alternative IKFs with a computer based search of the uiral protein database, targeting sequences from th~ alternative translation IKFs conforming to the HLA-A~I motif (38) . Numerous alternative OIKFs at the 5' end of the conventional O R F conformed to our parameters and we are currently determining the influence of such natural, cryptic epitopes in immune responses. Why have such epitopes not been previously identified? The most reasonable answer probably lies in the fact that there has not been a pressing need to identify them. Standard techniques for epitope detemfination focus on the primary O1KFs, with T cell clones that do not map to these regions being discarded. The extra effort required to investigate all three 1KFs would only be used in such prominent cases as tumor antigens or alloantigens. Recently, Malarkannan et al. (42) reported on an alloreactive epitope encoded in an alternative translation 1KF. Overlapping peptides failed to identify the epitope and its nature eluded the authors until they expressed the appropriate region in the different reading frames. This general sequence of events was also experienced with two epitopes expressed by human melanoma lines. One was shown to be partially encoded in an intron, for which expression is dependent upon aberrant splicing (17) . The second lies in an alternate reading frame of the gp75 gene (12) .
The recent report ofElliott et al. provides the first direct evidence for cryptic epitope expression in vivo (13) . This study and ours are similar in that both employ expression of NP via a recombinant vac system although in their case the NP gene product is preceded by a leader sequence. However, results of the two studies are strikingly different. EIliott et at. observed strong presentation of NP36(,_374 in vitro and clear presentation in vivo even though the product was shifted to the + 1 frame within codon 160. This frameshift is in close proximity to our FS-D (also a shift into the + 1 frame, at codon 151) which had very limited in vitro antigenicity. We did nor test the FS-D construct in vivo but given results with FS-B, FS-C, and FS-E we expect it would not stimulate a detectable response. The discrepancy may be due to the differing conditions of the in vitro assays used to detect expression of the epitope and to assess priming in vivo. A more intriguing possibility is that translation coupled with translocation (as would occur with a leaderencoded sequence) is more susceptible to frameshifting. Indeed, the structure of the E. coti ribosome, as recently deduced by low-dose cryoelectron microscopy (49, 50) , suggests that there are two channels through which the polypeptide can exit the ribosome. The exit of one channel is in the membrane associated domain of the 50S subunit and may therefore be reserved for translocated (secreted) proteins. It has been demonstrated that interactions of the nascent peptide with the exit channel can influence decoding by inducing transient mRNA/peptidyl tRNA dissociation and stalling (51, 52). Assuming a similar arrangement exists for eukaryotic ribosomes, perhaps exit through the exocytic channel induces a higher incidence of frameshifting as compared with exit through the cytosolic channel. The mechanism underlying expression of an epitope in an alternate reading frame of the melanoma-associated gp75 gene (12) has not yet been reported. Its position within the primary open reading frame (beginning 294 bases from the primary ATG) and the number of preceding ATG triplets (5) do not eliminate scanthrough as a possibility. However, this protein is exocytic (53, 54) and the same mechanism operating in conjunction with the exocytic version of NP may also be at work here.
Scanthrough translation may also have consequences for in-frame epitopes as well. We hypothesized that instability of the NP/32-498 product underlies presentation of FS-A and, further, that this product is a significant source of processing substrate in the expression of W T NP. However, presentation levels of the NP147_is 5 epitope from the N P / M32I mutant were indistinguishable from those associated with W T NP (Fig. 8) . Additionally, in experiments not shown, a BFA-mediated analysis demonstrated presentation of epitope from FS-A to be significantly lower than that from wild-type NP. Thus, we still do not understand the significance of the 1VI32 codon and do not yet have evidence that anything other than full-length NP provides the bulk of the starting processing substrate for generation of the epitopes in our study. However, for other proteins it remains possible that truncated products generated by scanthrough account for significant quantities of epitope. Further, other mechanisms that would generate truncated products, such as premature termination, remain to be investigated.
A second extension of our findings involves the presentation of M H C class I epitopes derived from exocytic proteins. It has been generally assumed that the M H C class I-restricted presentation of these proteins is the result ofmis-translation, resulting in the cytosolic proteolysis and processing of a fragment of these proteins that is not translocated into the endoplasmic reticulum (ER) (3, 37, 55) . More recently, it has been proposed that a mammalian equivalent of the US 11 gene of cytomegalovirus (CMV) may actively expel misformed membrane proteins from the ER. into the cytosol, whereupon they can be rapidly degraded (56) . In addition to these mechanisms, we wish to propose that ribosomes scanning through primary initiation codons and initiating from downstream codons, thereby bypassing the leader sequence required for ER translocation, may make a significant contribution to the substrate for processing and presentation ofexocytic proteins.
The expression of cryptic epitopes could have an important imnaunological impact and physiological relevance in areas such as thymic education, CTL mediated autoimmunity, vaccine design and cancer immunotherapy. Further investigations in this area should help elucidate the potential influence of the inherent flexibility of translation in the development of immune responses.
